Scarica l'app Stockscreener
21.81
0.32%
-0.07
Dopo l'orario di chiusura:
21.81
Vera Therapeutics Inc Borsa (VERA) Ultime notizie
Does Vera Therapeutics Inc. stock pay reliable dividendsRapid market gains - jammulinksnews.com
Vera Therapeutics Inc. Stock Analysis and ForecastFree Predictions - PrintWeekIndia
What analysts say about Vera Therapeutics Inc. stockLightning-fast capital gains - Autocar Professional
Why Vera Therapeutics Inc. stock is on top investor watchlistsRemarkable growth - jammulinksnews.com
What drives Vera Therapeutics Inc. stock priceFree Trading Strategy Suggestions - Autocar Professional
Is Vera Therapeutics Inc. a good long term investmentBreakthrough profit margins - jammulinksnews.com
Polycythemia Vera Pipeline 2025: Latest FDA Approvals, - openPR.com
Fund Remains in Vera Therapeutics Short-Swing Trading Lawsuit - Bloomberg Law News
Vera Therapeutics Reports Positive Phase 3 ORIGIN Trial Results for Atacicept in IgA Nephropathy - MSN
how vera therapeutics inc. stock performs during market volatilityFree Deep Market Trend Analysis - Newser
How Vera Therapeutics Inc. stock performs during market volatilityReal Chart Play - Newser
What makes Vera Therapeutics Inc. stock price move sharplyFree Stock Market Forums - Newser
Why Vera Therapeutics Inc. stock attracts strong analyst attentionStable Growth Stock Picks - Newser
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Vera Therapeutics announces refinancing of Oxford debt facility with access to up to $500M in term loans - MSN
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Vera Therapeutics Expands Team with 200K+ Shares in Stock Options and RSUs for New Hires - Stock Titan
Polycythemia Vera Clinical Trials 2025: EMA, PDMA, FDA - openPR.com
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):